CRP and AA amyloidosis: The subclinical inflammation may continue during attack-free periods in FMF patients, and despite reflecting attacks with high sensitivity, value of the classical acute phase reactants (ESR and CRP) for the prediction of subclinical inflammation may progress to AA amyloidosis (15, 16).